What are the consequences of stopping pirfenidone?
Pirfenidoneis a pyridone compound with broad-spectrum anti-fibrosis effect. Its chemical name is5-methyl-1-phenyl-2-(1H)pyridone. The drug is already widely used to treat idiopathic pulmonary fibrosis (IPF) and has been approved by the U.S. Food and Drug Administration. Pirfenidone can not only prevent and reverse fibrosis and scar formation, but also shows good efficacy in fibrotic diseases such as renal interstitial fibrosis and liver fibrosis.

In terms of drug mechanism, pirfenidone plays an anti-fibrotic effect by regulating or inhibiting certain factors, reducing the biological activity of fibroblasts, inhibiting cell proliferation and matrix collagen synthesis. At the same time, it can also inhibit the secretion of inflammatory mediators, reduce lipid peroxidation, etc., and exert anti-inflammatory and antioxidant effects.
However, discontinuation of pirfenidone is not arbitrary. Stopping the medication can have a number of consequences. First, stopping the drug may cause symptoms originally controlled by the drug to return, and may even become more severe. That's because pirfenidone is key to relieving symptoms for many patients. Secondly, drugs will produce certain physiological effects in the body. These effects may gradually disappear after stopping the drug, causing the body to adapt to a new state, which may cause discomfort to the patient. In addition, for patients who have been dependent on drugs for a long time, sudden discontinuation of drugs may cause psychological discomfort, such as anxiety, depression, etc.
Therefore, patients should follow their doctor's advice when taking pirfenidone and do not stop taking it at will. If you really need to stop taking the drug, you should gradually reduce the dose under the guidance of a doctor to reduce the impact on the body. At the same time, you should pay close attention to your physical condition during the withdrawal process and provide feedback to your doctor at any time so that you can adjust your treatment plan in a timely manner.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)